Scaffold-Free Cartilage Construct via Micro-Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing cartilage injuries, such as fibrocartilage stimulation, osteochondral grafting, and autologous chondrocyte transplantation, face challenges including poor mechanical properties, immune reactions, and limited attachment of engineered tissue constructs to the defect bed, leading to inadequate healing and potential complications like tissue rejection.
Innovation Solution
A method for in-vitro production of a cohesive cartilage construct involving the propagation of chondrogenic cells in a hypoxic environment, facilitating contact between cartilage micro constructs through gentle movement, and subjecting them to mechanical stimulation to form a cohesive cartilage construct with mechanical properties similar to native cartilage, without the use of biological or synthetic scaffolds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If scaffolds are used to support engineered tissue constructs, then structural integrity is improved, but immune reactions and rejection risks increase
Solution Approach 1:
The invention removes scaffolds entirely from the tissue engineering process. Cartilage constructs are formed without any scaffold support, eliminating the source of immune reactions while maintaining structural integrity through self-assembly of cartilage microconstructs
Solution Approach 2:
The cartilage constructs serve their own structural support function through self-assembly. Chondrogenic cells naturally organize into microconstructs that fuse together to form load-bearing cartilage tissue without requiring external scaffold support
2Object-affected harmful factors
If cartilage constructs are formed without scaffolds, then immune reactions are minimized, but attachment to defect bed is limited
Solution Approach 1:
The invention uses multiple small cartilage microconstructs (200-600 μm) instead of a single large construct. These segmented microconstructs can individually attach to the defect bed and then fuse together, improving overall attachment reliability while maintaining scaffold-free construction
Solution Approach 2:
The invention changes the size parameter of cartilage constructs to the microscale (200-600 μm). This size optimization enables sufficient surface area for attachment to the defect bed while maintaining the scaffold-free advantage of minimized immune reactions
3Reliability
If fibrocartilage is stimulated for repair, then temporary symptomatic relief is achieved, but mechanical properties remain poor
Solution Approach 1:
The invention uses chondrogenic cells (which produce hyaline cartilage) instead of fibroblasts (which produce fibrocartilage). This cell type selection creates local tissue quality with superior mechanical properties while maintaining the ability to provide symptomatic relief
Solution Approach 2:
The invention creates engineered hyaline cartilage tissue that combines the benefits of biological tissue (symptomatic relief) with optimized mechanical properties through controlled cell culture and microconstruct formation, surpassing the mechanical limitations of fibrocartilage
4Strength
If osteochondral grafting is performed, then mechanical properties are improved, but donor-site morbidity and disease transmission risk increase
Solution Approach 1:
The invention uses the patient's own chondrogenic cells to create the cartilage construct in vitro. The cells self-organize into microconstructs that fuse to form the graft, eliminating the need for donor site harvesting and associated morbidity while maintaining mechanical properties
Solution Approach 2:
The invention replaces the mechanical harvesting and transplantation of osteochondral grafts with a biochemical process of cell culture and microconstruct formation. This substitution eliminates disease transmission risk and donor-site morbidity while producing grafts with appropriate mechanical properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces a cohesive cartilage construct with mechanical properties consistent with native cartilage, enhancing the likelihood of successful transplantation and reducing recovery time by promoting effective tissue integration and minimizing immune reactions.
Implementation Method 1
propagating chondrogenic cells derived from a subject in a hypoxic environment to allow formation of one or more cartilage micro constructs
Implementation Method 2
subjecting one or more of the fused cartilage micro constructs to mechanical stimulation in a hypoxic environment to allow formation of a cohesive cartilage construct
Data Source
AI summary
A method for in-vitro production of a cohesive cartilage construct includes the following steps: a) propagating chondrogenic cells derived from a subject to allow formation of one or more cartilage micro constructs; b) putting a plurality of the cartilage micro constructs in motion to facilitate contact between the cartilage micro constructs and thereby allow formation of one or more fused cartilage micro constructs; and c) subjecting one or more of the fused cartilage micro constructs to mechanical stimulation in a hypoxic environment to allow formation of a cohesive cartilage construct.